Related Experiment Videos
Usefulness of olanzapine in refractory panic attacks
Journal of Clinical Psychopharmacology
|January 25, 2003
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Eye-tracking working memory intervention in young people with severe dyskinetic cerebral palsy: a pilot study.
Disability and rehabilitation. Assistive technology·2026
Enhancing the understanding and clinical utility of P300 in psychotic disorders: the contribution of a bimodal oddball paradigm.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Descrição atualizada da paralisia cerebral.
Developmental medicine and child neurology·2026
The cerebral palsy directed acyclic graph: A structural causal model of aetiology.
Developmental medicine and child neurology·2026
Updated description of cerebral palsy.
Developmental medicine and child neurology·2026
Memantine Augmentation for Obsessive-Compulsive Symptoms in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
Journal of clinical psychopharmacology·2026
Partial Dopamine Agonists and Gambling Disorder: A Comprehensive Review and Clinical Implications.
Journal of clinical psychopharmacology·2026
Unintentional Lithium Toxicity in Patients With Bipolar Disorder: A Literature Review of Case Reports.
Journal of clinical psychopharmacology·2026
Comparative Effectiveness of Pharmacogenomics for Treatment of Depression.
Journal of clinical psychopharmacology·2026
Olanzapine/Samidorphan-Associated Opioid Withdrawal Reported to US Poison Centers.
Journal of clinical psychopharmacology·2026
Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States.
Prostate cancer and prostatic diseases·2026
Clinical Approach to Impulse Control-Related Behavioral Disorders in Parkinson's Disease: A Scoping Review.
Movement disorders clinical practice·2026
Researchers struggle to improve nonopioid pain drugs.
Science (New York, N.Y.)·2026